Loading interface...

Scodia 750 MG Tablet

Manufactured byApex Laboratories Pvt. Ltd.
ContainsMetformin
Description

Scodia 750 MG Tablet is an effective first choice medicine used to control high blood glucose levels in patients with type II diabetes. Patients are advised to maintain a strict exercise and diet regimen along with this medicine to get the best possible effect. It helps in minimizing the risk of diabetes-associated complications such as blindness, kidney damage, stroke, and heart attack.

Side effects

Major & minor side effects for Scodia 750 MG Tablet

  • Nausea and vomiting
  • Diarrhea
  • Abdominal pain
  • Loss of appetite
  • Weakness
  • Chest discomfort
  • Headache
  • Runny Nose
  • Belching and Heartburn
  • Swollen joints

Uses of Scodia 750 MG Tablet

What is it prescribed for?

  • Type II Diabetes Mellitus
  • Polycystic Ovary Syndrome
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1 to 2 hours of administration.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 4 to 8 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to metformin, any other biguanides, or inactive ingredients present along with the formulation.

Metabolic Acidosis

This medicine is not recommended for use in patients with metabolic acidosis since it may worsen the patient's condition.

Severe kidney impairment

This medicine is not recommended for use in patients with severe impairment of kidney function due to the increased risk of serious adverse effects.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Lactic Acidosis

This medicine may cause lactic acidosis, which may be fatal, in some patients. This risk is especially higher in patients suffering from heart diseases, kidney diseases, etc. Report any unusual symptoms to the doctor immediately. Replacement with a suitable alternative may be required based on the clinical condition.

Kidney diseases

This medicine should be used with caution in patients with a known history of kidney diseases due to the increased risk of worsening of the patient's condition. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Stress

The use of this medicine should be discontinued in patients exposed to stressful conditions such as fever, trauma, surgeries, or accidents since it may not be effective in controlling blood sugar levels in these conditions. Replacement with a suitable alternative should be considered under your doctor's supervision.

Type I diabetes

This medicine is not recommended for use in patients suffering from Type I diabetes since it is not effective in treating such patients.

Diarrhea

This medicine may cause diarrhea when therapy is initiated. In most cases, diarrhea subsides by itself. Contact your doctor if the problem persists for a longer duration. Therapy may need to be discontinued in some cases based on the clinical condition.

Vitamin B12 deficiency

This medicine should be used with extreme caution in patients with vitamin B12 deficiency since it may worsen the patient's condition. Appropriate vitamin B12 supplementation and dose adjustments may be required in some cases.

Missed Dose

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Interaction with Medicine

Amlodipine

Estradiol

Gatifloxacin

Iodinated Contrast Media

Aloe Vera

Formoterol

Disease interactions

Vitamin B12 deficiency

This medicine should be used with extreme caution in patients with vitamin B12 deficiency since it may worsen the patient's condition. Appropriate vitamin B12 supplementation and dose adjustments may be required based on the clinical condition.

Cardiovascular disease

This medicine should be administered with extreme caution in patients suffering from a disease of the heart or blood vessels due to the increased risk of serious adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Lactic Acidosis

This medicine may cause lactic acidosis in some patients. This risk is especially higher in patients with kidney diseases, heart diseases, or septicemia. Close monitoring of blood glucose levels, kidney function, heart function, and liver function may be required for such patients based on the clinical condition. Report any symptoms such as fatigue, breathing difficulty, increased sleep, nausea, vomiting, diarrhea, irregular heartbeat, etc. to the doctor immediately. Appropriate corrective measures and discontinuation of therapy may be required in some cases based on the clinical condition.

Hypoglycemia

This medicine should be used with extreme caution in patients taking other antidiabetic agents (e.g. sulfonylureas, insulin, or meglitinides) or who are predisposed to hypoglycemic episodes due to the risk of hypoglycemia. Close monitoring of blood glucose levels is recommended for such patients. Appropriate dose adjustments may be required based on the blood glucose levels.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine exactly as prescribed by the doctor. Your dose is likely to change over time based on therapeutic response and clinical condition. Regular monitoring of blood sugar levels is recommended during treatment with this medicine. You should always carry a sugar candy with you to counteract an unexpected lowering of blood sugar levels. Do not change the dose or duration of use without consulting your doctor.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine decreases the absorption of glucose from the intestines and increases the action of insulin in the body
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Non-sulfonylureas, Oral Biguanides

Schedule

Schedule H

DailyMed - Metformin hcl tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 1 March 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d98aea3-35ba-447a-b88f-a5a20b612b2f

Metformin | C4H11N5 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 1 March 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/4091

[Internet]. 2017 [cited 18 October 2017]. Available from:

https://www.medicines.org.uk/emc/PIL.26348.latest.pdf

Metformin: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2020 [cited 19 February 2020]. Available from:

https://medlineplus.gov/druginfo/meds/a696005.html

Johnson N. Metformin use in women with polycystic ovary syndrome [Internet]. PubMed Central (PMC). 2020 [cited 19 February 2020]. Available from:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200666/

[Internet]. Ajog.org. 2020 [cited 19 February 2020]. Available from:

https://www.ajog.org/article/S0002-9378(08)01047-8/pdf

[Internet]. Royalberkshire.nhs.uk. 2020 [cited 19 February 2020]. Available from:

https://www.royalberkshire.nhs.uk/patient-information-leaflets/endocrinology-use-of-metformin-in-pcos
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 11 May 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.